ERBB2 and breast carcinoma: Interestingly, HER2+ circulating tumour cells (CTCs) isolated from an ER+/HER2− breast cancer patient were previously shown to spontaneously interconvert from HER2− and HER2+, with cells harbouring a phenotype producing daughters of the opposite one60.